RTSM in Clinical Trials: Key Features to Look for Before Choosing a System

Choosing an RTSM system is about more than finding a tool that can randomize patients. Trial teams also have to consider how the system will manage study supply, site activity, treatment allocation, and mid-trial changes. The right setup fits the study, so your team isn’t forced to bend its processes around the software.

When you evaluate RTSM in clinical trials, put your attention on the features that will count across the whole study, not only at setup. A system can look perfect in a demo, but the real test comes once sites are enrolling patients and handling supply day after day.

Flexible Randomization

Randomization is one of the main functions of an RTSM system. The system should be able to support the randomization method required by the study protocol, whether that involves simple allocation, block randomization, stratification, or other more specific approaches.

It is also worth checking how the system handles changes. Some studies have different cohorts, treatment groups, or enrollment limits. A system that can accommodate these requirements without creating unnecessary manual work can make study management easier.

Clear Supply Visibility

Randomization is only one part of the process. Trial teams also need to know where study supply is, what is available, and what each site may need next.

A useful clinical trial supply management setup should provide visibility into inventory at relevant sites and depots. This can help teams keep track of available kits, shipments, returns, and other supply activity from one place.

Look for a system that puts supply information in one clear view, so your team isn’t piecing it together from several different sources.

Resupply That Fits the Study

Supply needs can change as enrollment moves along. One site might recruit patients quickly, while another may take much longer. A supply plan that stays the same throughout the study may not work well in both cases.

RTSM software can use enrollment and dispensing activity to help decide when more supply is needed. Depending on the study, resupply may be based on stock levels, expected demand, or a request made manually by the study team.

There is no single approach that works for every study. What matters is whether the resupply method suits the study and gives your team enough visibility to notice low stock early. It should also make it easier to see when a site’s supply needs a closer look.

Strong Blinding Controls

In a blinded study, treatment information has to be kept under control. Not everyone working on the trial should be able to see the same information. If emergency unblinding is needed, it should also follow the process set out for the study.

When comparing RTSM systems, look at how they control user access and what happens when an unblinding event occurs. The system should keep a record of these events and make the steps easy to follow. This is better than relying on staff to handle the process manually.

Reliable Data and Audit Trails

Clinical trial systems deal with information that needs to be accurate and easy to trace. FDA guidance says computerized systems used in clinical trials should keep reliable records and track changes through an audit trail.

When reviewing an RTSM, check how it records randomization, supply activity, user actions, and changes made to study information. It is also important to look at user access. Each person should have access only to the information and functions they need for their role.

Easy Handling of Study Changes

Protocols can change once a study is already underway. Enrollment rules might be updated, new countries could be added, or the study may need a different approach to supply.

Before choosing an RTSM, find out how it handles changes after the study has gone live. The system should let the team make the needed updates in a controlled way, while still allowing those changes to be tested and documented properly.

This is important because what works at the start of a trial may not be enough later on. As the study changes, the RTSM should be able to keep up with it.

Simple Reporting and Useful Support

Reports are another thing to check before choosing an RTSM. Study teams may need reports on enrollment, inventory, shipments, or randomization activity. If getting this information means doing several exports and checking everything manually, it can create extra work.

Support during the study is worth looking at as well. ICH E6(R3) highlights the need for suitable procedures and training when computerized systems are used in clinical trials. Having a clear support process can help when the team has questions about the system or needs to make changes during the study.

What Should You Check Before Choosing

There is no single RTSM setup that will suit every study. The requirements will depend on the protocol, study design, number of sites, supply model, and level of blinding.

Before making a choice, it can help to review the system against the actual needs of the study. Look at how it handles randomization, supply tracking, resupply, access control, reporting, and changes after launch. It is also useful to understand how the system will be tested and supported once the study is underway.

Taking this approach can make the selection process more practical. Instead of choosing a system based only on a feature list, trial teams can focus on whether it will work well for the study they actually need to run.